Mole L - Search Results

1

Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.

Hafner R, Bethel J, Power M, Landry B, Banach M, Mole L, Standiford HC, Follansbee S, Kumar P, Raasch R, Cohn D, Mushatt D, Drusano G. Hafner R, et al. Among authors: mole l. Antimicrob Agents Chemother. 1998 Mar;42(3):631-9. doi: 10.1128/AAC.42.3.631. Antimicrob Agents Chemother. 1998. PMID: 9517944 Free PMC article. Clinical Trial.

2

Tolerance and pharmacokinetic interactions of rifabutin and azithromycin.

Hafner R, Bethel J, Standiford HC, Follansbee S, Cohn DL, Polk RE, Mole L, Raasch R, Kumar P, Mushatt D, Drusano G; DATRI 001B Study Group. Hafner R, et al. Among authors: mole l. Antimicrob Agents Chemother. 2001 May;45(5):1572-7. doi: 10.1128/AAC.45.5.1572-1577.2001. Antimicrob Agents Chemother. 2001. PMID: 11302832 Free PMC article. Clinical Trial.

3

Human immunodeficiency virus reverse transcriptase codon 215 mutations diminish virologic response to didanosine-zidovudine therapy in subjects with non-syncytium-inducing phenotype.

Holodniy M, Katzenstein D, Mole L, Winters M, Merigan T. Holodniy M, et al. Among authors: mole l. J Infect Dis. 1996 Oct;174(4):854-7. doi: 10.1093/infdis/174.4.854. J Infect Dis. 1996. PMID: 8843229

4

Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment.

Katzenstein DA, Holodniy M, Israelski DM, Sengupta S, Mole LA, Bubp JL, Merigan TC. Katzenstein DA, et al. Among authors: mole la. J Acquir Immune Defic Syndr (1988). 1992;5(2):107-12. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1732501

5

The impact of active herpes simplex virus infection on human immunodeficiency virus load.

Mole L, Ripich S, Margolis D, Holodniy M. Mole L, et al. J Infect Dis. 1997 Sep;176(3):766-70. doi: 10.1086/517297. J Infect Dis. 1997. PMID: 9291329

6

Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.

Holodniy M, Mole L, Margolis D, Moss J, Dong H, Boyer E, Urdea M, Kolberg J, Eastman S. Holodniy M, et al. Among authors: mole l. J Virol. 1995 Jun;69(6):3510-6. doi: 10.1128/JVI.69.6.3510-3516.1995. J Virol. 1995. PMID: 7745698 Free PMC article.

7

Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.

Mole L, Margolis D, Carroll R, Todd J, Holodniy M. Mole L, et al. J Clin Microbiol. 1994 Sep;32(9):2212-5. doi: 10.1128/jcm.32.9.2212-2215.1994. J Clin Microbiol. 1994. PMID: 7814549 Free PMC article.

8

Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient.

Mole L, Israelski D, Bubp J, O'Hanley P, Merigan T, Blaschke T. Mole L, et al. J Acquir Immune Defic Syndr (1988). 1993 Jan;6(1):56-60. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8417175

9

Diurnal and short-term stability of HIV virus load as measured by gene amplification.

Holodniy M, Mole L, Winters M, Merigan TC. Holodniy M, et al. Among authors: mole l. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):363-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7907661

10

CD20 expression is increased on B lymphocytes from HIV-infected individuals.

Staal FJ, Roederer M, Bubp J, Mole LA, Anderson MT, Raju PA, Israelski DM, Deresinski SC, Moore WA, Herzenberg LA, et al. Staal FJ, et al. Among authors: mole la. J Acquir Immune Defic Syndr (1988). 1992;5(6):627-32. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1375291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters